Neurocrine Biosciences | 流動負債





流動負債 変化する 日付
AbbVie USD 39.39B 376M 2025-09
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Agios Pharmaceuticals USD 74.76M 4.35M 2025-09
ALKERMES USD 474.36M 31.6M 2025-09
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
Amgen USD 21.79B 1.32B 2025-09
Biogen USD 3.29B 106.3M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Cytokinetics USD 142.14M 11.08M 2025-09
Dynavax Technologies USD 106.84M 11.39M 2025-09
Exelixis USD 373.78M 37.67M 2025-09
Gilead Sciences USD 12.3B 1.11B 2025-09
Halozyme Therapeutics USD 837.23M 702.95M 2025-09
Incyte USD 1.34B 60.11M 2025-09
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Neurocrine Biosciences USD 638M 91.7M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Prothena USD 51.44M 16.37M 2025-09
Regeneron Pharmaceuticals USD 4.43B 758.1M 2025-09
Repligen USD 131.14M 8.12M 2025-09
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 4.48B 336.9M 2025-09


Neurocrine Biosciences 流動負債 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.